ResourceLife Sciences
Luminex FLEXMAP 3D bead-based vs. MSD planar multiplex immunoassays for plasma cytokine profiling in brain tumor subjects
1 Dec 2021In this application note, Luminex compares the performance of two 96-well multiplex immunoassay platforms for assessing plasma cytokine concentrations in people with glioblastoma, melanoma, breast or lung cancer metastases to the brain, and healthy volunteers.
Related Products
Request Quote for All Products
Luminex™ xMAP™ INTELLIFLEX DR-SE System
LuminexThe Luminex xMAP INTELLIFLEX System is the newest addition to the xMAP line of instruments. It comes in two configurations: the Luminex xMAP INTELLIFLEX System and the Luminex xMAP INTELLIFLEX DR-SE System. The main differences between the configurations are the dual reporter and side eject features available in the DR-SE configuration.